Finger cuff vs. arm cuff: which better predicts brain bleeding after stroke?
NCT ID NCT03359434
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 455 stroke patients to see if a continuous finger blood pressure monitor (Clearsight) or standard arm cuff measurements better predict brain bleeding after clot removal. Each patient had both methods used within 24 hours after treatment. The goal was to see which method more accurately identifies those at risk for intracranial hemorrhage.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to predict brain bleeding after stroke treatment, helping doctors choose the best monitoring method.
- What could go wrong
- This is an observational study comparing measurement methods, not testing a new treatment. Results may not change current practice or apply to all stroke patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
455 people
The number who actually took part.
- Started
-
Dec 2018
- Finished
-
Dec 2024
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with thrombectomy after acute stroke
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient aged 18 years or older * Treated for occlusion of the internal carotid arteries and/or proximal middle cerebral arteries (M1 and M2 segments), vertebral artery, and/or basilar artery * Affiliated with or beneficiary of a Social Security plan * Having received informed information about the study and having given consent to participate in the study Exclusion Criteria: * Per-procedure hemorrhagic complications (before reperfusion is achieved) * Patient benefiting from legal protection measures * Pregnant or breastfeeding women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute ischemic stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondation Ophtalmologique A de Rothschild
Paris, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a kidney protein drug boost stroke recovery after clot removal?
- Can PET scans reveal hidden heart inflammation after a stroke?
- Can an implanted heart monitor catch hidden irregular heartbeats after stroke?
- China builds national watchdog for brain blood vessel devices
- Can a vegan diet shield police officers from heart disease?
- Can a Plant-Based diet program help patients lose weight and improve heart health?